Hamieh, Mohamad
Dobrin, Anton
Cabriolu, Annalisa
van der Stegen, Sjoukje J. C.
Giavridis, Theodoros
Mansilla-Soto, Jorge
Eyquem, Justin
Zhao, Zeguo
Whitlock, Benjamin M.
Miele, Matthew M.
Li, Zhuoning
Cunanan, Kristen M.
Huse, Morgan
Hendrickson, Ronald C.
Wang, Xiuyan
Rivière, Isabelle
Sadelain, Michel
Article History
Received: 26 March 2018
Accepted: 21 February 2019
First Online: 27 March 2019
Competing interests
: Memorial Sloan Kettering has submitted patent applications based in part on results presented in this manuscript (PCT/US18/68134, which has been licensed to several companies; M. Hamieh, J.M.-S. and M.S. are listed among the inventors; US provisional application no. 62/807,181; M. Hamieh and M.S. are listed among the inventors). R.C.H. reports stock ownership in Merck. I.R. and M.S. report research funding from Juno Therapeutics, Fate Therapeutics, Takeda Pharmaceuticals and Atara Biotherapeutics. I.R. serves on the scientific advisory board of Flow Design and M.S. on those of Berkeley Lights and St Jude Children Research Hospital.